Long-term trial on the effect of mulberry leaf extract ingestion on postprandial glycemic control in pre-diabetic subjects

Long-term trial on the effect of mulberry leaf extract ingestion on postprandial glycemic control in pre-diabetic subjects - Long-term trial on the effect of mulberry leaf extract ingestion on postprandial glycemic control in pre-diabetic subjects

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000003155

Enrollment

Registered

2010-03-01

Start date

2008-02-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

diabetes

Interventions

placebo tablet ingestion three times daily before each meals for 12 weeks

blood collection at week 0, 4, 8 and 12 of the ingestion period and at 4-week after withdrawal Mulberry leaf extract tablet ingestion three times daily before each meals for 12 weeks

blood collection at week 0, 4, 8 and 12 of the ingestion period and at 4-week after withdrawal

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Fasting plasma glucose in the range of 100-140 mg/dl

Exclusion criteria

Exclusion criteria: pregnancy, lactation, severe medical illnesses, and the concurrent use of any agent for the control of blood glucose

Design outcomes

Primary

Measure	Time frame
Fasting blood glucose, insulin, 1,5-anhydroglucitol, glycated hemoglobin, glycated albumin	—

Countries

Japan

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026